# Evidence-Based Novel Changes in Prevalence and Symptom Characteristics of Spleen Deficiency Syndrome in Persons of Varied Health Status and Different Ages: A Cross-Sectional Observational Study

Authors: Yin Zhang; Yue Liu; Xian-ping Li; Jian Li; Xiao-feng Li; Liang Chen; Yu-yong Jiang; Hao Yu; Ning Shi; Mei Han; Hui Ye; Zi-han Lin; Yue-zhou Chen; Fu-sheng Liu; Xia Ding
Journal: Evidence-Based Complementary and Alternative Medicine
 (2014)

---

## Abstract

Deficiency of the organs is a vital pathophysiologic characteristic in the elderly. A core TCM aging theory is known as aging caused by spleen deficiency syndrome (SDS) that can be found in ancient and modern literature. The key objectives of this study were to establish a full-scale trial to evaluate the prevalence, symptom severity, frequency, and distribution of SDS in different age groups as related to health status (healthy, subhealthy, and chronic disease) to elucidate the role of spleen deficiency in the aging process and deterioration of health status. This cross-sectional observational study was conducted in 4 hospitals in China. 1390 participants aged 20–79 were interviewed by investigators who completed questionnaires recording prevalence, severity, and frequency of symptoms as well as other relevant information. The results revealed that prevalence and symptom characteristics of SDS showed regularities with increasing age and deteriorating health status. It supports the TCM concept that spleen deficiency is an important mechanism of aging, subhealth, and chronic diseases. Early recognition of the warning signs and symptoms of SDS may lead to intervention and even prevention strategies for subhealth and chronic diseases as well as promotion of healthy aging.


---

## Body

## 1. Introduction

Aging is a spontaneous, long-term, gradual, complex, and inevitable process recognized by modern medicine as physiologic deterioration and decline. The key tenet of traditional Chinese medicine (TCM) is the Chinese philosophic concept of holism [1], with aging an ongoing pathophysiologic process that occurs in response to influences external to the organism as well as to internal functional decline of the organs, meridians, flow ofqi and blood, andyin andyang.Deficiency of the organs is a vital pathophysiologic characteristic in the elderly. A core TCM aging theory is known as aging caused by spleen deficiency. Evidence supporting this theory can be found in ancient and modern literature [2–7]. Earliest mention may have been in theYellow Emperor’s Inner Classic(Huangdi Nei Jing). Since ancient times dating to the Han dynasty (200s CE), this theory has played a crucial role in preventing disease, promoting longevity, and the delivery of daily health care in China. Modern clinical and laboratory studies have explored the essence of spleen deficiency syndrome (SDS) as well as the correlation between SDS and the digestive system [8, 9].Chinese society is aging at an unprecedented rate [10, 11]. There will be an estimated 438 million elderly in China by 2050, occupying 21.8% of the world’s elderly population (2 billion) [12, 13]. Although longevity is a symbol of good health and shows global health improvement, the growing demand for health services for the aging population is a major challenge for medical and social services not only in China, but also worldwide [13].The issue of health, subhealth (suboptimal health), chronic disease, and geriatrics has attracted widespread attention in China [14–18] and has been clearly defined by medical professionals [19–21]. In terms of TCM, health is defined as optimal physiologic functioning in self-regulation, adaptation to the environment, resistance against pathogens, and self-recovery from illness. Subhealth and chronic disease are the result of physiologic dysfunction that can be differentiated into TCM pathogenic patterns, or syndromes, of excess or deficiency of the organs,qi, blood, andyin andyang.Epidemiologic studies have demonstrated the correlation between SDS and health status (subhealth and chronic disease). Results show the percentage of the spleen deficiency population quadruples for both males and females between 20–30 years old and 50–60 years old, a growth rate of more than 10 percent per decade demonstrating that compared with the young and middle-aged the elderly have a much higher prevalence of SDS [14, 15, 22–24]. SDS is one of the most common syndromes in the subhealthy and chronic disease populations and is complicated by other complex syndromes [25–28].There are several shortcomings in existing epidemiologic studies on SDS though progresses have been made in gaining a better understanding of this syndrome as related to aging. None of these studies describe age-related changes of SDS in symptom severity, frequency, and distribution in addition to prevalence. None of the studies compare the differences in varied health status populations. In addition, their poor quality control in statistical analyses and study design precludes reliability of their results.In this context, we designed the present study to evaluate the prevalence, symptom severity, frequency, and distribution of SDS in different age and health status (healthy, subhealthy, and chronic disease) groups so as to address these limitations. Our key objective was to elucidate the role of spleen deficiency in the aging process and deterioration of health status objectively and systematically.


## 2. Methods

### 2.1. Study Design and Participants

This cross-sectional study was conducted between April 2009 and August 2013. Inpatients, outpatients, and individuals were recruited by simple random sampling from hospitals in Beijing and Xiamen, China: Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine; Xiamen Traditional Chinese Medicine Hospital; Peking Union Medical College Hospital Affiliated to the Chinese Academy of Medical Sciences; and Beijing Hospital Affiliated to the National Health and Family Planning Commission of China. All participants involved in this survey signed consent forms, the numbers of which were evenly distributed in all four seasons.


### 2.2. Diagnostic Criteria

Diagnostic criteria of SDS were based on the China Association of Integrative Medicine Reference Guideline for Traditional Chinese Medicine Deficiency Syndrome Differentiation [29]. For this study, participants presenting with at least three of the five following signs and symptoms, loose stools, abdominal distension following meals, sallow complexion, loss of appetite, weight loss, and general weakness, were diagnosed with SDS.Diagnostic criteria of subhealth were based onClinical Guidelines of Chinese Medicine on Subhealth published by the China Association of Chinese Medicine [20]. After physical examination and appropriate diagnostic testing, patients were diagnosed as subhealthy when they presented with several defined somatic, psychologic, or social adaptation symptoms that had lasted at least 3 months.Diagnostic criteria of chronic disease were specialty-based. Diagnoses were reached after detailed evaluation, including medical history, physical examination, and diagnostic testing.Participants who meet the criteria of neither subhealth nor chronic disease were diagnosed as healthy.


### 2.3. Inclusion and Exclusion Criteria

Inclusion criteria were 20–79 years of age; signed informed consent; meeting diagnostic criteria of health, subhealth, or chronic disease; willingness to respond to investigator queries truthfully while completing the clinical observation questionnaires.Potential participants who did not meet the age requirement or any of the above-mentioned diagnostic criteria, were unwilling to sign the consent form, were unwilling or unable to complete questionnaires, or had mental disorders were excluded at screening.


### 2.4. Questionnaire Content and Administration

A clinical observation questionnaire was designed for survey of participants to capture data on TCM symptoms based on deficiency syndrome differentiation guidelines [29]. In addition, demographic information (name, gender, and age), disease information (chief complaint, present and past medical history), and subhealth-related information (physical, psychologic, and social adaptation symptoms) were also included in this questionnaire. A list of detailed definitions of severity and frequency of symptoms was prepared for investigators and participants to refer to as additional file to questionnaires. To ensure quality control, investigators at each medical center received training on standard operating procedure before the study began. Each participant was interviewed by two or more resident TCM physicians based on questionnaire after enrollment in the study with at least two senior physicians supervising each interview session.


### 2.5. Statistical Analysis

Comparative analysis of SDS prevalence in different age and health status groups was expressed as composition ratio and performed by frequency analysis and chi-square test. Comparative analysis of quantitative scores of the severity and frequency of symptoms was performed by rank-sum test. A probability ofP
<
0.05 was considered statistically significant. Regression analysis of correlation of SDS occurrence and potential factors was performed by nonconditional binary logistic stepwise regression of numerical variables. Significance level of introducing and removing variables was 0.05 and 0.10, respectively. All statistical analyses were performed by SPSS software (version 17.0, SPSS Inc., Chicago, IL) in this study.


## 2.1. Study Design and Participants

This cross-sectional study was conducted between April 2009 and August 2013. Inpatients, outpatients, and individuals were recruited by simple random sampling from hospitals in Beijing and Xiamen, China: Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine; Xiamen Traditional Chinese Medicine Hospital; Peking Union Medical College Hospital Affiliated to the Chinese Academy of Medical Sciences; and Beijing Hospital Affiliated to the National Health and Family Planning Commission of China. All participants involved in this survey signed consent forms, the numbers of which were evenly distributed in all four seasons.


## 2.2. Diagnostic Criteria

Diagnostic criteria of SDS were based on the China Association of Integrative Medicine Reference Guideline for Traditional Chinese Medicine Deficiency Syndrome Differentiation [29]. For this study, participants presenting with at least three of the five following signs and symptoms, loose stools, abdominal distension following meals, sallow complexion, loss of appetite, weight loss, and general weakness, were diagnosed with SDS.Diagnostic criteria of subhealth were based onClinical Guidelines of Chinese Medicine on Subhealth published by the China Association of Chinese Medicine [20]. After physical examination and appropriate diagnostic testing, patients were diagnosed as subhealthy when they presented with several defined somatic, psychologic, or social adaptation symptoms that had lasted at least 3 months.Diagnostic criteria of chronic disease were specialty-based. Diagnoses were reached after detailed evaluation, including medical history, physical examination, and diagnostic testing.Participants who meet the criteria of neither subhealth nor chronic disease were diagnosed as healthy.


## 2.3. Inclusion and Exclusion Criteria

Inclusion criteria were 20–79 years of age; signed informed consent; meeting diagnostic criteria of health, subhealth, or chronic disease; willingness to respond to investigator queries truthfully while completing the clinical observation questionnaires.Potential participants who did not meet the age requirement or any of the above-mentioned diagnostic criteria, were unwilling to sign the consent form, were unwilling or unable to complete questionnaires, or had mental disorders were excluded at screening.


## 2.4. Questionnaire Content and Administration

A clinical observation questionnaire was designed for survey of participants to capture data on TCM symptoms based on deficiency syndrome differentiation guidelines [29]. In addition, demographic information (name, gender, and age), disease information (chief complaint, present and past medical history), and subhealth-related information (physical, psychologic, and social adaptation symptoms) were also included in this questionnaire. A list of detailed definitions of severity and frequency of symptoms was prepared for investigators and participants to refer to as additional file to questionnaires. To ensure quality control, investigators at each medical center received training on standard operating procedure before the study began. Each participant was interviewed by two or more resident TCM physicians based on questionnaire after enrollment in the study with at least two senior physicians supervising each interview session.


## 2.5. Statistical Analysis

Comparative analysis of SDS prevalence in different age and health status groups was expressed as composition ratio and performed by frequency analysis and chi-square test. Comparative analysis of quantitative scores of the severity and frequency of symptoms was performed by rank-sum test. A probability ofP
<
0.05 was considered statistically significant. Regression analysis of correlation of SDS occurrence and potential factors was performed by nonconditional binary logistic stepwise regression of numerical variables. Significance level of introducing and removing variables was 0.05 and 0.10, respectively. All statistical analyses were performed by SPSS software (version 17.0, SPSS Inc., Chicago, IL) in this study.


## 3. Results

### 3.1. Characteristics of Participants

1495 questionnaires were distributed and a total of 1427 (95.45%) were completed. 1390 forms were deemed eligible for the study after eliminating questionnaires with incomplete information, with a rate of 97.4%. In terms of age distribution, 508 participants were aged 20 to 39, 472 were aged 40 to 59, and 410 were aged 60–79. As for health status distributions, 366 were characterized as healthy, 745 were subhealthy, and 279 were experiencing chronic disease. There were 682 males and 708 females, a gender ratio of 0.963.


### 3.2. Prevalence of SDS in the Same Health Status but Different Ages

Prevalence of SDS in the same health status group showed a significant rising trend with increasing age (Table1, Figure 1). Prevalence in persons 40–59 years of age was higher than in persons 20–39 years of age and was lower than in persons 60–79 years of age (P
=
0.012 and P
=
0.009, resp.). In the subhealthy group, SDS prevalence demonstrated a similar rising tendency as age increased. Comparisons between the 20–39 and 40–59 age groups and between the 40–59 and 60–79 age groups were both statistically significant (P
=
0.001 and P
=
0.018, resp.). SDS prevalence in persons with chronic disease did not appear significantly different between the 40–59 and 60–79 age groups (P
>
0.05). However, compared with these two groups, prevalence in the 20–39 age group was lower (P
=
0.034 and P
=
0.011, resp.).Table 1
Age and prevalence of SDS.
Health status
Total number
SDS, total number (%)
Age group, SDS number (%)
20–39 y
40–59 y
60–79 y
Healthy
366
136 (37.2)
39 (22.9)
41 (39.0)
56 (61.5)
Subhealthy
745
262 (35.2)
69 (24.0)
110 (37.4)
83 (50.6)
Chronic disease
279
160 (57.3)
21 (41.2)
43 (58.9)
96 (61.9)Figure 1
Trend in SDS prevalence with increasing age. Data from 3 independent age groups were presented as percentage.


### 3.3. Prevalence of SDS in Varied Health Status within the Same Age Group

In each age group, SDS prevalence varied by health status (Table2, Figure 2). In the 20–39-year and 40–59-year age groups, compared with the healthy and subhealthy groups, SDS prevalence rose when physical condition worsened, while in the 60–79-year age group there was no such trend. In the 20–39-year age group, persons with chronic disease had a higher prevalence of SDS compared with healthy and subhealth individuals (P
=
0.005 and P
=
0.011, resp.). In the 40–59-year age group, SDS prevalence of persons with chronic disease was also higher than in healthy and subhealthy persons (P
=
0.013 and P
=
0.003, resp.). In the 60–79-year age group, prevalence was even lower in subhealthy participants compared with the healthy and chronic disease groups (P
<
0.001 and P
=
0.003, resp.). In the 20–39 and 40–59-year age groups, comparisons of SDS prevalence between healthy and subhealthy participants were not significantly different (P
>
0.05). However, in the 60–79-year age group, comparison of SDS prevalence between healthy participants and those with chronic disease also showed no significant difference.Table 2
Health status and prevalence of SDS.
Age group, y
Total, number
SDS, total number (%)
Health status, SDS number (%)
Healthy
Subhealthy
Chronic disease
20–39
508
129 (25.4)
39 (22.9)
69 (24.0)
21 (41.2)
40–59
472
194 (41.1)
41 (39.0)
110 (37.4)
43 (58.9)
60–79
410
235 (57.3)
56 (61.5)
83 (50.6)
96 (61.9)Figure 2
Trend in SDS prevalence with deterioration of health. Data from 3 independent health status groups were presented as percentage.


### 3.4. Severity and Frequency of SDS-Related Symptoms

Definitions of severity and frequency of the five spleen deficiency symptoms (loose stools, abdominal distension following meals, sallow complexion, loss of appetite, weight loss, and general weakness) were attached to the questionnaire for participants and investigators to refer to. Symptom severity was assigned the following scores: asymptomatic = 0; mild = 1; moderate = 2; severe = 3. Symptom frequency was assigned the following scores: never = 0; occasional = 1; intermittent = 2; often = 3.SDS Symptom Severity and Frequency at Different Ages. Symptom severity scores in the 40–59 age group were higher than in the younger age group (P
<
0.001). Symptoms were more severe in the 60–79 age group than in the middle-aged (P
<
0.001) (Table 3, Figure 3). Comparisons of symptom frequency scores among the three groups were all statistically significant (P
<
0.001), indicating that SDS-related symptoms present more frequently with increasing age (Tables 3 and 4, Figure 3).Table 3
SDS symptom severity scores at different ages.
Age, number
Score
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
20–39
162
97
81
53
32
21
23
6
6
11
9
4
2
1
0
40–59
102
65
57
52
44
49
24
30
12
9
10
11
5
2
0
60–79
48
51
47
59
51
27
23
26
12
17
13
18
16
2
0
Total
312
213
185
164
127
97
70
62
30
37
32
33
23
5
0Table 4
SDS symptom frequency scores at different ages.
Age, number
Score
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
20–39
310
52
56
25
18
8
21
7
2
6
2
1
0
0
0
40–59
213
64
26
41
43
14
21
15
13
10
3
4
2
1
2
60–79
150
43
24
19
21
30
31
50
27
5
6
1
1
2
0
Total
673
169
106
85
82
52
73
62
42
21
11
6
3
3
2Figure 3
Trends in severity and frequency of SDS-related symptoms with increasing age. Data from 3 independent age groups were presented as mean (standard deviation).SDS Symptom Severity and Frequency as Related to Health Status. Symptom severity and frequency scores were not significantly different between the three health status groups (P
>
0.05) (Tables 5 and 6, Figure 4).Table 5
SDS symptom severity scores in varied health status.
Group, number
Score
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Health
103
47
46
20
33
10
13
16
6
18
15
17
21
1
0
Subhealth
169
154
108
95
51
57
34
33
10
9
9
9
2
4
0
Chronic disease
40
12
31
49
43
30
23
13
14
10
8
7
0
0
0
Total
312
213
185
164
127
97
70
62
30
37
32
33
23
5
0Table 6
SDS symptom frequency scores of SDS in varied health status.
Group, number
Score
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Health
165
41
32
13
27
9
20
48
4
6
1
0
0
0
0
Subhealth
395
91
44
53
29
31
35
10
29
10
8
6
2
2
0
Chronic disease
113
37
30
19
26
12
18
4
9
5
2
0
1
1
2
Total
673
169
106
85
82
52
73
62
42
21
11
6
3
3
2Figure 4
Trends in severity and frequency of SDS symptoms with deteriorating health. Data from 3 independent health status groups were presented as mean (standard deviation).


### 3.5. Prevalence of SDS and Potential Factors

Unconditional binary logistic stepwise regression of numerical variables was applied to evaluate the correlation of SDS prevalence and other potential related factors including age, health status, and symptoms. Significance level of entered and removed variables was 0.05 and 0.10, respectively.Independent variables wereχ
1 gender, χ
2 age, χ
3 health status, χ
4 loose stools, χ
5 abdominal distension after meal, χ
6 sallow complexion, χ
7 loss of appetite, and χ
8 weight loss and weakness. Dependent variable y represented whether or not participants met SDS diagnostic criteria. The logistic regression equation was
(1)
y
=
5.903
-
0.216
χ
2
-
0.512
χ
3
-
1.430
χ
4
-
1.176
χ
5
-
1.482
χ
6
-
1.679
χ
7
-
0.405
χ
8
.Results showed that age, health status, loose stools, abdominal distension after meal, sallow complexion, loss of appetite, and weight loss and weakness contributed to the prevalence of SDS (P
<
0.05); none of these variables had an OR > 1. Gender did not affect prevalence of SDS (P
>
0.05).


### 3.6. SDS Symptoms as Related to Health Status and Different Ages

Among healthy individuals, prevalence of SDS symptoms was markedly higher with increasing age. Prevalence of loss of appetite increased less precipitously than other symptoms (Table7, Figure 5). Prevalence of loose stools in persons 60–79 years of age was almost twice that of 20–30 and 40–59-year-olds. Prevalence between these two latter age groups remained steady.Table 7
Prevalence of SDS symptoms as related to health status and age.
Health status
Age group
Total (n)
Loose stools
Abdominal distension after meal
Sallow complexion
Loss of appetite
Weight loss and weakness
Healthy
20–39
170
58 (34.1%)
52 (30.6%)
41 (24.1%)
59 (34.7%)
37 (21.8%)
40–59
105
36 (34.3%)
47 (44.8%)
42 (40.0%)
43 (41.0%)
53 (50.5%)
60–79
91
52 (57.1%)
54 (59.3%)
50 (55.0%)
42 (46.2%)
52 (57.1%)
Subhealthy
20–39
287
119 (41.5%)
96 (33.4%)
67 (23.3%)
103 (36.3%)
50 (17.4%)
40–59
294
121 (41.2%)
123 (41.8%)
159 (54.1%)
93 (31.6%)
120 (40.8%)
60–79
164
74 (45.1%)
73 (44.5%)
92 (56.1%)
65 (39.6%)
83 (50.6%)
Chronic disease
20–39
51
29 (56.9%)
30 (58.8%)
14 (27.5%)
13 (25.5%)
37 (72.5%)
40–59
73
30 (41.1%)
39 (53.4%)
51 (69.9%)
44 (60.3%)
47 (64.4%)
60–79
155
78 (50.3%)
80 (51.6%)
108 (69.7%)
86 (55.5%)
80 (51.6%)Figure 5
Distribution of SDS-related symptoms in healthy people of different ages. Data from 3 independent age groups were presented as percentage.In the subhealthy group, prevalence of abdominal distension and loose stools rose slowly with increasing age. Sallow complexion and weight loss and weakness accelerated significantly between 20–39 and 40–59 years of age and slowed markedly between 40–59 and 60–79 years of age. Prevalence of loss of appetite declined between 20–39 and 40–59 years of age but increased between 40–59 and 60–79 years of age (Table7, Figure 6).Figure 6
Distribution of SDS-related symptoms in subhealthy people of different ages. Data from 3 independent age groups were presented as percentage.Among persons with chronic disease, prevalence of both abdominal distension and weight loss and weakness exhibited decline with increasing age. Loose stools also declined between the 20–39- and 40–59-year-olds but then increased between the 40–59- and 60–79-year-olds. Loss of appetite rose sharply between 20–39 and 40–59 years of age, but this symptom improved between ages 40–59 and 60–79 (Table7, Figure 7).Figure 7
Distribution of SDS symptoms in persons with chronic disease at different ages. Data from 3 independent age groups were presented as percentage.Prevalence of SDS symptoms exhibited certain trends as health status deteriorated. Among the 20–39 age group, prevalence of loose stools, abdominal distension, and sallow complexion rose slowly, with loss of appetite then decreasing and abdominal distension increasing markedly in the chronic disease group (Table7, Figure 8). Prevalence of weight loss and weakness declined slowly between healthy and subhealthy persons and increased dramatically between subhealthy and chronic disease individuals.Figure 8
Distribution of SDS symptoms in 20–39 age group of different health status. Data from 3 independent health status groups were presented as percentage.In the 40–59 age group, prevalence of weight loss and weakness, loss of appetite, and abdominal distension showed decline between healthy and subhealthy persons, followed by sharp increase in the chronic disease group. Prevalence of sallow complexion increased steadily as health status worsened (Table7, Figure 9).Figure 9
Distribution of SDS symptoms in 40–59 age group of different health status. Data from 3 independent health status groups were presented as percentage.In persons 60–79 years old, prevalence of all symptoms except sallow complexion declined between the healthy and subhealthy groups. Prevalence of sallow complexion rose slightly between healthy and subhealthy individuals and then rose markedly in the chronic disease group (Table7, Figure 10). In all three health status groups, sallow complexion had the highest prevalence of all SDS symptoms (Table 7, Figures 8–10).Figure 10
Distribution of SDS symptoms in 60–79 age group of different health status. Data from 3 independent health status groups were presented as percentage.


## 3.1. Characteristics of Participants

1495 questionnaires were distributed and a total of 1427 (95.45%) were completed. 1390 forms were deemed eligible for the study after eliminating questionnaires with incomplete information, with a rate of 97.4%. In terms of age distribution, 508 participants were aged 20 to 39, 472 were aged 40 to 59, and 410 were aged 60–79. As for health status distributions, 366 were characterized as healthy, 745 were subhealthy, and 279 were experiencing chronic disease. There were 682 males and 708 females, a gender ratio of 0.963.


## 3.2. Prevalence of SDS in the Same Health Status but Different Ages

Prevalence of SDS in the same health status group showed a significant rising trend with increasing age (Table1, Figure 1). Prevalence in persons 40–59 years of age was higher than in persons 20–39 years of age and was lower than in persons 60–79 years of age (P
=
0.012 and P
=
0.009, resp.). In the subhealthy group, SDS prevalence demonstrated a similar rising tendency as age increased. Comparisons between the 20–39 and 40–59 age groups and between the 40–59 and 60–79 age groups were both statistically significant (P
=
0.001 and P
=
0.018, resp.). SDS prevalence in persons with chronic disease did not appear significantly different between the 40–59 and 60–79 age groups (P
>
0.05). However, compared with these two groups, prevalence in the 20–39 age group was lower (P
=
0.034 and P
=
0.011, resp.).Table 1
Age and prevalence of SDS.
Health status
Total number
SDS, total number (%)
Age group, SDS number (%)
20–39 y
40–59 y
60–79 y
Healthy
366
136 (37.2)
39 (22.9)
41 (39.0)
56 (61.5)
Subhealthy
745
262 (35.2)
69 (24.0)
110 (37.4)
83 (50.6)
Chronic disease
279
160 (57.3)
21 (41.2)
43 (58.9)
96 (61.9)Figure 1
Trend in SDS prevalence with increasing age. Data from 3 independent age groups were presented as percentage.


## 3.3. Prevalence of SDS in Varied Health Status within the Same Age Group

In each age group, SDS prevalence varied by health status (Table2, Figure 2). In the 20–39-year and 40–59-year age groups, compared with the healthy and subhealthy groups, SDS prevalence rose when physical condition worsened, while in the 60–79-year age group there was no such trend. In the 20–39-year age group, persons with chronic disease had a higher prevalence of SDS compared with healthy and subhealth individuals (P
=
0.005 and P
=
0.011, resp.). In the 40–59-year age group, SDS prevalence of persons with chronic disease was also higher than in healthy and subhealthy persons (P
=
0.013 and P
=
0.003, resp.). In the 60–79-year age group, prevalence was even lower in subhealthy participants compared with the healthy and chronic disease groups (P
<
0.001 and P
=
0.003, resp.). In the 20–39 and 40–59-year age groups, comparisons of SDS prevalence between healthy and subhealthy participants were not significantly different (P
>
0.05). However, in the 60–79-year age group, comparison of SDS prevalence between healthy participants and those with chronic disease also showed no significant difference.Table 2
Health status and prevalence of SDS.
Age group, y
Total, number
SDS, total number (%)
Health status, SDS number (%)
Healthy
Subhealthy
Chronic disease
20–39
508
129 (25.4)
39 (22.9)
69 (24.0)
21 (41.2)
40–59
472
194 (41.1)
41 (39.0)
110 (37.4)
43 (58.9)
60–79
410
235 (57.3)
56 (61.5)
83 (50.6)
96 (61.9)Figure 2
Trend in SDS prevalence with deterioration of health. Data from 3 independent health status groups were presented as percentage.


## 3.4. Severity and Frequency of SDS-Related Symptoms

Definitions of severity and frequency of the five spleen deficiency symptoms (loose stools, abdominal distension following meals, sallow complexion, loss of appetite, weight loss, and general weakness) were attached to the questionnaire for participants and investigators to refer to. Symptom severity was assigned the following scores: asymptomatic = 0; mild = 1; moderate = 2; severe = 3. Symptom frequency was assigned the following scores: never = 0; occasional = 1; intermittent = 2; often = 3.SDS Symptom Severity and Frequency at Different Ages. Symptom severity scores in the 40–59 age group were higher than in the younger age group (P
<
0.001). Symptoms were more severe in the 60–79 age group than in the middle-aged (P
<
0.001) (Table 3, Figure 3). Comparisons of symptom frequency scores among the three groups were all statistically significant (P
<
0.001), indicating that SDS-related symptoms present more frequently with increasing age (Tables 3 and 4, Figure 3).Table 3
SDS symptom severity scores at different ages.
Age, number
Score
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
20–39
162
97
81
53
32
21
23
6
6
11
9
4
2
1
0
40–59
102
65
57
52
44
49
24
30
12
9
10
11
5
2
0
60–79
48
51
47
59
51
27
23
26
12
17
13
18
16
2
0
Total
312
213
185
164
127
97
70
62
30
37
32
33
23
5
0Table 4
SDS symptom frequency scores at different ages.
Age, number
Score
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
20–39
310
52
56
25
18
8
21
7
2
6
2
1
0
0
0
40–59
213
64
26
41
43
14
21
15
13
10
3
4
2
1
2
60–79
150
43
24
19
21
30
31
50
27
5
6
1
1
2
0
Total
673
169
106
85
82
52
73
62
42
21
11
6
3
3
2Figure 3
Trends in severity and frequency of SDS-related symptoms with increasing age. Data from 3 independent age groups were presented as mean (standard deviation).SDS Symptom Severity and Frequency as Related to Health Status. Symptom severity and frequency scores were not significantly different between the three health status groups (P
>
0.05) (Tables 5 and 6, Figure 4).Table 5
SDS symptom severity scores in varied health status.
Group, number
Score
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Health
103
47
46
20
33
10
13
16
6
18
15
17
21
1
0
Subhealth
169
154
108
95
51
57
34
33
10
9
9
9
2
4
0
Chronic disease
40
12
31
49
43
30
23
13
14
10
8
7
0
0
0
Total
312
213
185
164
127
97
70
62
30
37
32
33
23
5
0Table 6
SDS symptom frequency scores of SDS in varied health status.
Group, number
Score
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Health
165
41
32
13
27
9
20
48
4
6
1
0
0
0
0
Subhealth
395
91
44
53
29
31
35
10
29
10
8
6
2
2
0
Chronic disease
113
37
30
19
26
12
18
4
9
5
2
0
1
1
2
Total
673
169
106
85
82
52
73
62
42
21
11
6
3
3
2Figure 4
Trends in severity and frequency of SDS symptoms with deteriorating health. Data from 3 independent health status groups were presented as mean (standard deviation).


## 3.5. Prevalence of SDS and Potential Factors

Unconditional binary logistic stepwise regression of numerical variables was applied to evaluate the correlation of SDS prevalence and other potential related factors including age, health status, and symptoms. Significance level of entered and removed variables was 0.05 and 0.10, respectively.Independent variables wereχ
1 gender, χ
2 age, χ
3 health status, χ
4 loose stools, χ
5 abdominal distension after meal, χ
6 sallow complexion, χ
7 loss of appetite, and χ
8 weight loss and weakness. Dependent variable y represented whether or not participants met SDS diagnostic criteria. The logistic regression equation was
(1)
y
=
5.903
-
0.216
χ
2
-
0.512
χ
3
-
1.430
χ
4
-
1.176
χ
5
-
1.482
χ
6
-
1.679
χ
7
-
0.405
χ
8
.Results showed that age, health status, loose stools, abdominal distension after meal, sallow complexion, loss of appetite, and weight loss and weakness contributed to the prevalence of SDS (P
<
0.05); none of these variables had an OR > 1. Gender did not affect prevalence of SDS (P
>
0.05).


## 3.6. SDS Symptoms as Related to Health Status and Different Ages

Among healthy individuals, prevalence of SDS symptoms was markedly higher with increasing age. Prevalence of loss of appetite increased less precipitously than other symptoms (Table7, Figure 5). Prevalence of loose stools in persons 60–79 years of age was almost twice that of 20–30 and 40–59-year-olds. Prevalence between these two latter age groups remained steady.Table 7
Prevalence of SDS symptoms as related to health status and age.
Health status
Age group
Total (n)
Loose stools
Abdominal distension after meal
Sallow complexion
Loss of appetite
Weight loss and weakness
Healthy
20–39
170
58 (34.1%)
52 (30.6%)
41 (24.1%)
59 (34.7%)
37 (21.8%)
40–59
105
36 (34.3%)
47 (44.8%)
42 (40.0%)
43 (41.0%)
53 (50.5%)
60–79
91
52 (57.1%)
54 (59.3%)
50 (55.0%)
42 (46.2%)
52 (57.1%)
Subhealthy
20–39
287
119 (41.5%)
96 (33.4%)
67 (23.3%)
103 (36.3%)
50 (17.4%)
40–59
294
121 (41.2%)
123 (41.8%)
159 (54.1%)
93 (31.6%)
120 (40.8%)
60–79
164
74 (45.1%)
73 (44.5%)
92 (56.1%)
65 (39.6%)
83 (50.6%)
Chronic disease
20–39
51
29 (56.9%)
30 (58.8%)
14 (27.5%)
13 (25.5%)
37 (72.5%)
40–59
73
30 (41.1%)
39 (53.4%)
51 (69.9%)
44 (60.3%)
47 (64.4%)
60–79
155
78 (50.3%)
80 (51.6%)
108 (69.7%)
86 (55.5%)
80 (51.6%)Figure 5
Distribution of SDS-related symptoms in healthy people of different ages. Data from 3 independent age groups were presented as percentage.In the subhealthy group, prevalence of abdominal distension and loose stools rose slowly with increasing age. Sallow complexion and weight loss and weakness accelerated significantly between 20–39 and 40–59 years of age and slowed markedly between 40–59 and 60–79 years of age. Prevalence of loss of appetite declined between 20–39 and 40–59 years of age but increased between 40–59 and 60–79 years of age (Table7, Figure 6).Figure 6
Distribution of SDS-related symptoms in subhealthy people of different ages. Data from 3 independent age groups were presented as percentage.Among persons with chronic disease, prevalence of both abdominal distension and weight loss and weakness exhibited decline with increasing age. Loose stools also declined between the 20–39- and 40–59-year-olds but then increased between the 40–59- and 60–79-year-olds. Loss of appetite rose sharply between 20–39 and 40–59 years of age, but this symptom improved between ages 40–59 and 60–79 (Table7, Figure 7).Figure 7
Distribution of SDS symptoms in persons with chronic disease at different ages. Data from 3 independent age groups were presented as percentage.Prevalence of SDS symptoms exhibited certain trends as health status deteriorated. Among the 20–39 age group, prevalence of loose stools, abdominal distension, and sallow complexion rose slowly, with loss of appetite then decreasing and abdominal distension increasing markedly in the chronic disease group (Table7, Figure 8). Prevalence of weight loss and weakness declined slowly between healthy and subhealthy persons and increased dramatically between subhealthy and chronic disease individuals.Figure 8
Distribution of SDS symptoms in 20–39 age group of different health status. Data from 3 independent health status groups were presented as percentage.In the 40–59 age group, prevalence of weight loss and weakness, loss of appetite, and abdominal distension showed decline between healthy and subhealthy persons, followed by sharp increase in the chronic disease group. Prevalence of sallow complexion increased steadily as health status worsened (Table7, Figure 9).Figure 9
Distribution of SDS symptoms in 40–59 age group of different health status. Data from 3 independent health status groups were presented as percentage.In persons 60–79 years old, prevalence of all symptoms except sallow complexion declined between the healthy and subhealthy groups. Prevalence of sallow complexion rose slightly between healthy and subhealthy individuals and then rose markedly in the chronic disease group (Table7, Figure 10). In all three health status groups, sallow complexion had the highest prevalence of all SDS symptoms (Table 7, Figures 8–10).Figure 10
Distribution of SDS symptoms in 60–79 age group of different health status. Data from 3 independent health status groups were presented as percentage.


## 4. Discussion

This study aimed to determine how the TCM syndrome and symptoms of spleen deficiency manifest during human aging and health status deterioration. Our results found that as healthy and subhealthy persons aged, SDS prevalence rose steadily. By the time these two groups reached seniorhood, they exhibited nearly the same SDS prevalence as seniors with chronic disease. In the subhealthy group, prevalence approached the level of seniors, and in the healthy group, prevalence nearly equaled that of seniors, thus showing that there is a close relationship between SDS and aging. In addition, spleen deficiency may play a crucial role in chronic disease pathogenesis since as compared with young and middle-aged healthy and subhealthy individuals persons with chronic disease of the same ages had a much higher prevalence of SDS.Interestingly, SDS prevalence did not increase significantly between the middle-aged and seniors in persons with chronic disease. Middle age may be the turning point of the effects of SDS in persons with chronic disease, possibly indicating that spleen deficiency has less of an impact on health when they are older compared with healthy and subhealthy individuals of the same age.In 20–39-year-olds, SDS prevalence increased slightly as they became subhealthy, followed by a dramatic increase when they developed chronic disease. In the 40–59- and 60–79-year-olds SDS prevalence remained stable between the healthy and subhealthy statuses, and the decrease was significant between the subhealthy and chronic disease statuses. Explanation for these phenomena may be that the etiology and pathogenesis of aging as health declines from a state of subhealth to chronic disease are more complicated than predicted in the middle-aged and elderly. Except for spleen deficiency as a directly related factor in aging, which is mentioned explicitly in TCM classics, other factors may play roles in these processes, especially in seniorhood.SDS symptom severity scores showed a rising trend with increasing age and deteriorating health status, while such tendency did not exist for symptom frequency scores. It appears that age, health status, loose stools, abdominal distension after meal, sallow complexion, loss of appetite, weight loss, and weakness were contributing factors to SDS. Distribution of SDS symptoms in certain health status and age stages also showed dramatic irregularities.With an estimated prevalence of more than 60% [21, 30] and an overall increasing trend by age [31], the concept of subhealth based on TCM theory has received attention in Chinese general public and health professionals. There is severe concern that public health and social problems may result if the warning signs and symptoms of subhealth are not recognized and treated properly. As a consequence of untreated subhealth, chronic disease has become the leading causes of worldwide mortality [27]. In China, chronic disease has showed a rising incidence [32, 33] and causes 85% of annual deaths [34, 35]. 55% of Chinese elderly, affected by chronic disease, has three or more concomitant persistent conditions [36].Several previous single-centred or small-sampled studies have indicated the relationship between SDS prevalence, age, and general health status preliminarily [10, 11, 16, 17] and stated that SDS is always accompanied by other complex syndromes [15, 17, 37–40], the notions of which are partly consistent with ours. Our present large-scale study has attempted to overcome these shortcomings, allowing us to find compelling evidence of the role of spleen deficiency in the aging process and deterioration of health status.Several limitations of our study warrant mention. This was a cross-sectional study; therefore selection bias may exist because participants were recruited from urban hospitals in Beijing and Xiamen, China. The data extracted may not be representative of the rest of China where the prevalence of SDS and distribution of symptom severity and frequency may vary from those in Beijing and Xiamen. Moreover, a cross-sectional study can only provide a basis for associations but cannot establish causality between variables such as age, health status, symptom frequency, or severity scores and prevalence of SDS.Further exploration through longitudinal studies, including prospective cohort studies with long follow-up times, is needed. Results of such research can provide stronger evidence on the role of SDS in aging and health status-related processes. By testing the internal relationships of all the deficiency syndrome-related symptoms in SDS individuals based on feature selection, several symptoms have formed tight-knit groups, which indicate the complexity of evidence-based SDS model (Figure11). In view of this, modern computational solutions, including association rules, decision tree, and complex system entropy clustering analysis algorithms, can be applied to excavate underlying core rules of SDS efficiently and objectively.Figure 11
Feature selection based internal relationships of deficiency syndrome-related symptoms in SDS population. Lines of different widths represent the level of relevance between different symptoms. Several symptoms related to deficiency of qi (shortness of breath or wheezing), kidney (sexual dysfunction or infertility), lung (persistent cough with white sputum, easy to catch colds), stomach (abdominal pain relieved by pressure), yin (edema of face or feet, afternoon heat rising), and yang (slow sunken pulse) have formed tight-knit groups (lines in red) in SDS population.


## 5. Conclusions

This study appears to support the TCM concept that spleen deficiency is an important mechanism of aging, subhealth, and chronic diseases. Early recognition of the warning signs and symptoms of SDS may lead to intervention and even prevention strategies for subhealth and chronic diseases as well as promotion of healthy aging.



---

*Source: 818235-2014-11-11.xml*